Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:971-978, doi:10.1016/j.jacc.2008.06.019
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Idriss, N. K.
Right arrow Articles by Lip, G. Y.H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Idriss, N. K.
Right arrow Articles by Lip, G. Y.H.
Related Collections
Right arrowRelated Article

Hemoxygenase-1 in Cardiovascular Disease

Naglaa K. Idriss, MSc, Andrew D. Blann, PhD and Gregory Y.H. Lip, MD*

Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom


Figure 1
View larger version (13K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Schematic of Hemoxygenase-1–Catalyzed Biochemical Reactions

Hem released from red blood cells is enzymatically converted into carbon monoxide, bilirubin, and iron. The former is a vasodilator and promoter of angiogenesis. Bilirubin has potential antioxidant activity. Free ferrous iron has potential pro-oxidant activity, although this may be limited by its sequestration by ferritin.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement